about
RAS proto-oncogene in medullary thyroid carcinomaAssociation of HLA DQ4-DR8 haplotype with papillary thyroid carcinomasGene expression profiling associated with the progression to poorly differentiated thyroid carcinomasTERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomasAbility of the rhTSH stimulation test to predict relapse in patients with differentiated thyroid carcinoma, after long-term follow-up.Poorly differentiated and anaplastic thyroid carcinomas: chromosomal and oligo-array profile of five new cell lines.Retrospective analysis of 140 cases of medullary thyroid carcinoma followed-up in a single institution.2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancerA case of thyroid fibromatosis, a rare lesion of this gland.Review of clinical and pathological features of 93 cases of well-differentiated thyroid carcinoma in pediatric age at the Lisbon Centre of the Portuguese Institute of Oncology between 1964 and 2006.Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas.Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas.Expression and function of the chemokine receptor CCR7 in thyroid carcinomas.Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop.Lymph Node Metastases in Papillary and Medullary Thyroid Carcinoma Are Independent of Intratumoral Lymphatic Vessel Density.Anaplastic carcinoma and toxic multinodular goiter: an unusual presentation.Retrospective Analysis of 255 Papillary Thyroid Carcinomas ≤2 cm: Clinicohistological Features and Prognostic Factors.Differential methylation as a cause of allele dropout at the imprinted GNAS locus.Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical/prognostic behaviour.FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility.Metastatic follicular carcinoma associated with hyperthyroidism.Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene.PROP1 gene analysis in Portuguese patients with combined pituitary hormone deficiency.Aggressive pituitary lesion with a remarkably high Ki-67.TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.Clinical and genetic characterization of Portuguese patients with pseudohypoparathyroidism type Ib.External ear invasion from an anaplastic thyroid cancer.Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?Identification and characterization of two novel germline RET variants associated with medullary thyroid carcinoma.High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas.Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.Preoperative diagnosis of suspicious parathyroid adenomas by RT-PCR using mRNA extracted from leftover cells in a needle used for ultrasonically guided fine needle aspiration cytology.Authors' response: Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomasThe Importance of the 2015 American Thyroid Association Guidelines for Adults with Thyroid Nodules and Differentiated Thyroid Cancer in Minimising Overdiagnosis and Overtreatment of Thyroid CarcinomaIdentification of De Novo Germline Mutations in the HRPT2 Gene in Two Apparently Sporadic Cases with Challenging Parathyroid Tumor DiagnosesMutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletionsFamilial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutationsMapping a New Familial Thyroid Epithelial Neoplasia Susceptibility Locus to Chromosome 8p23.1-p22 by High-Density Single-Nucleotide Polymorphism Genome-Wide Linkage Analysis
P50
Q26796901-CEFF1A37-84C9-4DA1-A3C6-8CA6D0CCDD52Q28293273-75559F04-49F5-4A23-98B6-4CEE91C41E82Q30491720-B81B3C0E-6496-4EEA-9B26-70FCA8D6C0C1Q34313648-C5AE66EC-0AFD-4C8E-BFD9-F4AAA85171BEQ35042089-E1BF1EFB-B35C-461A-90CD-7ED091CDFA3FQ36610272-31D5C3C1-FAA8-41A5-B15E-A49F1C8421E5Q36954521-DAA4FF8F-8AA1-408F-AF6A-2529071A3F2BQ37290956-7E7779D4-5FE4-4EC9-B583-E147E39FD0EDQ37390140-EB56621A-8159-477B-98B1-D790AC4CB046Q38535983-869C4986-A6FA-493B-A9EA-8B2D909243B6Q38787337-434EB0F1-DF05-4881-B096-C19642D41E52Q38941691-3061E635-B950-4C51-BB34-D76440723630Q39034553-AE0B7FF6-AF47-4C25-AE52-7B3F45CBF860Q40215535-58C1E714-D2FC-4EB3-90FE-6378F23CA9F5Q40356195-A02B8FC2-75CA-4078-A6BB-B5E8EB532CB6Q41641233-3A9AD726-801E-4B26-AB88-8E3A67F14A7DQ42108776-237606D8-9903-4959-B5B1-D5F03B21A0C4Q42128468-89CBBD0B-629E-423F-B43D-C66590CD915BQ42966045-81E2A87E-E4FC-4233-A5B7-61B8712C65DAQ44683053-75381EBE-02D7-4686-BE34-564947B32F1DQ45198975-866426AD-6D93-4940-A3A0-C7B806850853Q45221940-0C639D14-37D2-4B3E-998D-E8A090666C17Q47799160-6D5430AF-BB4D-4CCD-A58E-D067F4458656Q48418100-40F6EAAA-E2E5-4F6A-B62A-7E332C9701F7Q48549777-EFF88E80-2AFE-45E7-9BF6-9E38D69293CAQ51092203-59801EA6-1F5F-408A-9B2B-4FB54D6E5309Q51909840-2E0227CC-3580-46B2-B058-BCFF7CABB0BEQ52604464-6E4AE5F0-0D11-4E72-BBE4-1313DCBB24F9Q53014880-1F7DDA4B-8686-4C28-B686-EF6A3BE6EE71Q53221095-D08EA6D9-D29B-42A8-9E2D-40BBAC29D007Q54287597-CDA40B7E-1D54-4AFA-A406-4963D885F089Q54387519-605C4160-B15B-4E17-823A-5C0F83C8B530Q54617217-89FD64CB-DDB0-4376-9E38-8591EFABDC2FQ54789645-1A76FB30-83E5-4D50-A3BC-7E48A01A3180Q57526255-BE3A6CE9-67CF-4174-82C7-EC2B100E0C17Q57652898-4A62DF71-5048-4226-B895-83B46F02E6F2Q58497279-02A8742F-DECF-4B9A-8238-545F06DB8D78Q60021516-D1185624-48D5-4E42-98D6-66A7EF61E588Q61785491-CD9E92F6-9E76-4254-9BFD-4536E659258DQ61785513-5F7135EB-BAB9-4ACD-A321-A81C08483FF2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Valeriano Leite
@ast
Valeriano Leite
@en
Valeriano Leite
@es
Valeriano Leite
@nl
Valeriano Leite
@sl
type
label
Valeriano Leite
@ast
Valeriano Leite
@en
Valeriano Leite
@es
Valeriano Leite
@nl
Valeriano Leite
@sl
altLabel
Valeriano Leite
@en
prefLabel
Valeriano Leite
@ast
Valeriano Leite
@en
Valeriano Leite
@es
Valeriano Leite
@nl
Valeriano Leite
@sl
P106
P1153
7005280097
P21
P31
P496
0000-0001-5479-7332